Retatrutide injections currently have no fixed commercial price in India because the drug has not yet received regulatory approval for retail sale. Cost is determined by the source of the compound, the dosage required, how many injections the protocol involves, and...
Retatrutide (reta) peptide causes side effects, primarily mild-to-moderate gastrointestinal issues like nausea, diarrhea, vomiting, and constipation. These are most common during initial dose escalation. While generally safe in trials, potential less common side...
No, retatrutide is not commercially available in India as an approved drug yet. It is currently in Phase 3 clinical trials globally and has not received regulatory approval from India's CDSCO or the US FDA for commercial sale as of now. However, physician-supervised...
MEDICALLY REVIEWED BY
Dr. Harikiran Chekuri
MBBS, MS – General Surgery, MCh-Plastic Surgery (Gold Medalist)
Plastic Surgeon, Hair Transplant Surgeon
